| ［1］ Hendrix SL, Clark A, Nygaard I, et al.Pelvic organ prolapse in the Women's Health Initiative: gravity and gravidity［J］. Am J Obstet Gynecol，2002, 186(6):1160-1166.［2］ Smith FJ, Holman CD, Moorin RE, et al.Lifetime risk of undergoing surgery for pelvic organ prolapse［J］. Obstet Gynecol，2010, 116(5):1096-1100.［3］ Abdel-Fattah M, Familusi A, Fielding S, et al.Primary and repeat surgical treatment for female pelvic organ prolapse and incontinence in parous women in the UK: a register linkage study［J］. BMJ Open,2011, 1(2):e000206.［4］ Withagen MI, Milani AL, den Boon J, et al.Trocar-guided mesh compared with conventional vaginal repair in recurrent prolapse: a randomized controlled trial［J］.Obstet Gynecol,2011, 117(2 Pt 1):242-250.［5］ Altman D, Vayrynen T, Engh ME, et al.Anterior colporrhaphy versus transvaginal mesh for pelvic-organ prolapse［J］. New Engl J Med，2011, 364(19):1826-1836.［6］ Food and Drug Administration. FDA safety communication: UPDATE on serious complications associated with transvaginal placement of surgical mesh for pelvic organ prolapse［EB/0L］.Silver Spring (MD) : FDA,2011,http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm262435.htm.［7］ Committee on Gynecologic Practice.Vaginal placement of synthetic mesh for pelvic organ prolapse［J］. Female Pelvic Med Reconstr Surg,2012, 18(1):5-9.［8］ 朱兰, 陈娟.关于美国FDA对经阴道网片安全警示的中国专家共识建议稿［C］. 北京：第八届北京大学女性盆底重建与微创手术研讨会论文集，2012: 10-14.［9］ Doaee M, Moradi-Lakeh M, Nourmohammadi A,et al.Management of pelvic organ prolapse and quality of life: a systematic review and meta-analysis［J］.Int Urogynecol J,2014, 25(2):153-163.［10］ Thiagamoorthy G, Cardozo L, Srikrishna S, et al.Management of prolapse in older women［J］.Post Reprod Health,2014, 20(1):30-35.［11］ Maher C, Feiner B, Baessler K, et al.Surgical management of pelvic organ prolapse in women［J］.Cochrane Database Syst Rev,2013, 4:CD004014.（2015-01-05收稿 2015-01-25修回） |
